公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan | Tseng K.-C.; Tseng C.-W.; Hsieh Y.-H.; CHIN-KUO CHANG ; Lai N.-S.; Hung T.-H.; Chang T.-T. | Human Immunology | 3 | 3 | |
2018 | Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV | CHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN | Gastroenterology | 95 | 82 | |
2002 | Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection | Tai D.-I.; CHIEN-HUNG CHEN ; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; JIN-CHUAN SHEU ; Liaw Y.-F.; DING-SHINN CHEN ; Sung J.-L. | Journal of Gastroenterology and Hepatology (Australia) | 25 | 21 | |
2020 | Fatty‐acid‐binding protein 4 as a novel contributor to mononuclear cell activation and endothelial cell dysfunction in atherosclerosis | YEN-WEN WU ; Chang T.-T.; Chang C.-C.; Chen J.-W. | International Journal of Molecular Sciences | 19 | 14 | |
2009 | Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: Identification of potential high HCV endemic areas | Su W.-W.; CHIEN-HUNG CHEN ; Lin H.H.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Wu J.-C.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Hepatology International | 13 | 10 | |
2009 | HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during Adefovir dipivoxil therapy | Tseng K.-C.; Cheng P.-N.; Wu I.-C.; CHIN-KUO CHANG ; Chou A.-L.; Liu W.-C.; Chang T.-T. | Hepato-Gastroenterology | 5 | 5 | |
2004 | Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma | CHIEN-HUNG CHEN ; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Liaw Y.-F.; Sung J.-L. | Journal of Hepatology | 44 | 32 | |
2011 | Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia | Chang H.-H, MENG-YAO LU ; Liao Y.-M.; Liao Y.-M.; YUNG-LI YANG ; Yang Y.-L.; Chiou S.-S.; SHIANN-TANG JOU ; Lin K.-H.; Chang T.-T.; Chang T.-T. | Pediatric Blood and Cancer | 32 | 24 | |
2006 | Improved treatment results for childhood acute myeloid leukemia in Taiwan | Liang D.-C.; Chang T.-T.; Lin K.-H.; Lin D.-T.; MENG-YAO LU ; Chen S.-H.; Liu H.-C.; Lin M.-T.; Lee M.-T.; Shu S.-G.; Chang T.-K.; Chen J.-S.; Hsiao C.-C.; Hung I.-J.; Hsieh Y.-L.; Chen R.-L.; Cheng S.-N.; Chang W.-H.; Lee C.-H.; Lin K.-S. | Leukemia | 37 | 32 | |
2009 | Individual differences in coping with criticism of one's physical appearance among Taiwanese students | Lu L.; Chang T.-T.; Kao S.-F.; Lee Y.-W.; LUO LU | International Journal of Psychology | 1 | 11 | |
2008 | The individual- and social-oriented Chinese bicultural self: A subcultural analysis contrasting mainland Chinese and taiwanese | Lu L.; Kao S.-F.; Chang T.-T.; Wu. H.-P.; Jin Z.; Bond M.; Uziel L.; Wang K.; Yang K.-S.; LUO LU | Social Behavior and Personality | 30 | 26 | |
2016 | Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus | Chuang W.-L.; Chien R.-N.; Peng C.-Y.; Chang T.-T.; Lo G.-H.; Sheen I.-S.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Gao B.; Garrison K.L.; Mo H.; Pang P.S.; Hsu Y.-C.; Hu T.-H.; Chu C.-J.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 24 | 20 | |
2010 | Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia | Liang D.-C.; Yang C.-P.; Lin D.-T.; Hung I.-J.; Lin K.-H.; Chen J.-S.; Hsiao C.-C.; Chang T.-T.; Peng C.-T.; Lin M.-T.; Chang T.-K.; Jaing T.-H.; Liu H.-C.; Wang L.-Y.; Yeh T.-C.; SHIANN-TANG JOU ; MENG-YAO LU ; Cheng C.-N.; Sheen J.-M.; Chiou S.-S.; Wu K.-H.; Hung G.-Y.; Chen R.-L.; Chen S.-H.; Cheng S.-N.; Chang Y.-H.; Chen B.-W.; Ho W.-L.; Wang J.-L.; Lin S.-T.; Hsieh Y.-L.; Wang S.-C.; HSIU-HAO CHANG ; YUNG-LI YANG ; Huang F.-L.; Chang C.-Y.; Chang W.-H.; Lin K.-S. | Leukemia | 78 | 72 | |
2006 | Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: Analysis of 11 312 patients in Taiwan | CHIEN-HUNG CHEN ; Su W.-W.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Journal of Gastroenterology and Hepatology (Australia) | 53 | 53 | |
2015 | MicroRNA-like small RNAs prediction in the development of antrodia cinnamomea | Lin Y.-L.; Ma L.-T.; Lee Y.-R.; Lin S.-S.; Wang S.-Y.; Chang T.-T.; Shaw J.-F.; Li W.-H.; SHIH-SHUN LIN ; FANG-HUA CHU | PLoS ONE | 26 | 22 | |
2017 | Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan | Yen H.-J.; Chen S.-H.; Chang T.-Y.; Yang C.-P.; Lin D.-T.; Hung I.-J.; Lin K.-H.; Chen J.-S.; Hsiao C.-C.; Chang T.-T.; Chang T.-K.; Peng C.-T.; Lin M.-T.; Jaing T.-H.; Liu H.-C.; SHIANN-TANG JOU ; MENG-YAO LU ; Cheng C.-N.; Sheen J.-M.; Chiou S.-S.; Hung G.-Y.; Wu K.-H.; Yeh T.-C.; Wang S.-C.; Chen R.-L.; HSIU-HAO CHANG ; YUNG-LI YANG ; Chen S.-H.; Cheng S.-N.; Chang Y.-H.; Chen B.-W.; Hsieh Y.-L.; Huang F.-L.; Ho W.-L.; Wang J.-L.; Chang C.-Y.; Chao Y.-H.; Lin P.-C.; Chen Y.-C.; Liao Y.-M.; Lin T.-H.; Shih L.-Y.; Liang D.-C. | Pediatric Blood and Cancer | 12 | 5 | |
2017 | Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients | Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN ; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S. | Frontiers in Immunology | 51 | 42 | |
2016 | Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) | Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN ; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team | Journal of Hepatology | 84 | 69 | |
2016 | A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection | JIA-HORNG KAO ; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L. | Liver International | 25 | 25 | |
2009 | A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan | Kuo Y.-C.; Yu C.-L.; CHEN-YU LIU ; Wang S.-F.; Pan P.-C.; Wu M.-T.; Ho C.-K.; Lo Y.-S.; Li Y.; Christiani D.C.; Chang T.-T.; Lin S.-F.; Chiou S.-S.; Jang R.-C.; Hsiao H.-H.; Liu T.-C.; Lin P.-C.; Hsiao C.-C.; Sheen J.-M.; Kuo C.-Y.; Wang M.-C.; Huang C.-H.; Huang C.-B.; Lin S.-J.; Sun Y.-M.; Hsieh K.-S.; Chang Y.-H.; Wong Y.-C.; Wu H.-B. | Cancer Causes and Control | 29 | 25 |